Discover 436 paid clinical trials in Edmonton, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Edmonton has a research history that most cities cannot match: the first successful islet cell transplant protocol for type 1 diabetes, known worldwide as the Edmonton Protocol, was developed at the University of Alberta in 2000 and changed transplant medicine. Diabetes studies are still a local strength, alongside cancer research at the Cross Cancer Institute, the comprehensive cancer centre for northern Alberta since 1968. Of the roughly 500 studies recruiting in the city, about a third are in oncology, with multiple myeloma and breast cancer among the most common, and the rest span inflammatory bowel disease, pulmonary hypertension, and sleep apnea.
Filter
2
Filter results
Results: 436
The Direct Oral Anticoagulation Versus Vitamin K Antagonist After Cardiac Surgery Trial
for
Bleeding Post Cardiac Surgery, Indication for Anticoagulation
A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B
for
Hemophilia B
Location: Edmonton, Aurora CO, Sacramento CA, San Francisco CA,
Sponsor: Regeneron Pharmaceuticals
Sex: Male
Age: 2+
Code: NCT06379789
Phase 1, Phase 2, Recruiting
Early Videocapsule Endoscopy for Upper Gastrointestinal Bleeding
for
Small Bowel Bleeding
Location: Edmonton
Sponsor: University of Alberta
Sex: All
Age: 18 - 70+
Code: NCT05108844
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Histology Wilms Tumors (FHWT)